# SCRN1

## Overview
SCRN1 is a gene that encodes the protein secernin-1, which is categorized as a cytosolic protein involved in the regulation of exocytosis. This protein plays a crucial role in cellular communication by facilitating the release of vesicle contents into the extracellular matrix, thereby influencing processes such as immune response, digestion, and cellular stress responses (Xiao2020Secernin; Xiao2023Knockdown). Secernin-1 is expressed in various tissues, with notable expression in the brain, testes, and ovaries, and is implicated in several physiological and pathological processes, including neurodegeneration and cancer (Suehara2011Secernin1; Pires2019Secernin1). The protein's interaction with phosphorylated tau in Alzheimer's disease highlights its potential as a therapeutic target (Drummond2020Phosphorylated; Pires2019Secernin1).

## Function
Secernin-1 (SCRN1) is a cytosolic protein primarily involved in the regulation of exocytosis, a process crucial for cellular communication and function. Exocytosis involves the release of vesicle contents into the extracellular matrix, which is essential for the delivery of surface proteins and the secretion of soluble factors such as growth factors and cytokines (Xiao2020Secernin; Xiao2023Knockdown). In healthy human cells, SCRN1 is expressed in various tissues, including the brain, testes, and ovaries, with minimal detection in other normal organs (Suehara2011Secernin1). 

SCRN1 is highly expressed in the brain, where it may play a role in regulating endoplasmic reticulum signaling and synaptic vesicle cycling in presynaptic terminals, although its specific function in physiological conditions remains poorly understood (Pires2019Secernin1). In the testes, SCRN1 is localized to the Sertoli cell cytoplasm and is expressed throughout the spermatogenic cycle, although it is dispensable for male fertility in mice (Houston2021The). The protein's involvement in exocytosis suggests it may influence processes like immune response and digestion, and it may also play a role in cellular stress responses and cell proliferation (Xiao2020Secernin).

## Clinical Significance
Alterations in the expression of the SCRN1 gene have been implicated in several diseases, particularly cancers and neurodegenerative disorders. In gastric cancer, the SCRN1 rs6976789 C.T polymorphism is associated with an increased risk and poorer prognosis, especially in intestinal-type gastric cancer. Individuals with the TT genotype of this polymorphism exhibit lower survival rates compared to those with CC/CT genotypes. This variant affects the binding ability of miR-148a, a tumor metastasis suppressor, potentially influencing SCRN1 expression and contributing to cancer progression (Song2014A).

In colorectal cancer, elevated SCRN1 expression is linked to a significantly lower post-operative overall survival rate. High SCRN1 expression serves as an independent predictor of overall survival, suggesting its role in tumor growth and poor prognosis (Miyoshi2010SCRN1).

SCRN1 is also associated with Alzheimer's disease (AD), where it accumulates in neurofibrillary tangles and plaque-associated dystrophic neurites. This accumulation is specific to AD and related conditions, such as Down syndrome with AD pathology, and is not observed in other tauopathies. The interaction between SCRN1 and phosphorylated tau suggests a potential role in AD pathogenesis, making it a possible therapeutic target (Pires2019Secernin1).

## Interactions
Secernin-1 (SCRN1) is a protein that has been identified as interacting with phosphorylated tau (pTau) in the context of Alzheimer's disease. This interaction is significant as SCRN1 co-localizes with pTau aggregates specifically in Alzheimer's disease, but not in other tauopathies such as Corticobasal Degeneration, Progressive Supranuclear Palsy, or Pick's disease (Pires2019Secernin1). The interaction between SCRN1 and pTau was validated through co-immunoprecipitation experiments, which confirmed the presence of SCRN1 in neurofibrillary tangles and its association with pTau in Alzheimer's disease brain tissue (Drummond2020Phosphorylated; Pires2019Secernin1).

SCRN1 is also involved in the regulation of exocytosis and has been associated with cancer, indicating its role in broader cellular processes beyond neurodegeneration (Pires2019Secernin1). In addition to its interactions in the brain, SCRN1 has been identified as a Sertoli cell-enriched protein in testicular interstitial fluid, suggesting its involvement in testicular function and potential interactions with other proteins in this context (O’Donnell2023Sertoli). These findings highlight the multifaceted roles of SCRN1 in different tissues and its potential as a therapeutic target in Alzheimer's disease.


## References


[1. (Song2014A) Peng Song, Haixia Zhu, Dong Zhang, Haiyan Chu, Dongmei Wu, Meiyun Kang, Meilin Wang, Weida Gong, Jianwei Zhou, Zhengdong Zhang, and Qinghong Zhao. A genetic variant of mir-148a binding site in the scrn1 3′-utr is associated with susceptibility and prognosis of gastric cancer. Scientific Reports, November 2014. URL: http://dx.doi.org/10.1038/srep07080, doi:10.1038/srep07080. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep07080)

[2. (O’Donnell2023Sertoli) Liza O’Donnell, Laura F. Dagley, Michael Curley, Annalucia Darbey, Peter J. O’Shaughnessy, Thorsten Diemer, Adrian Pilatz, Daniela Fietz, Peter G. Stanton, Lee B. Smith, and Diane Rebourcet. Sertoli cell-enriched proteins in mouse and human testicular interstitial fluid. PLOS ONE, 18(9):e0290846, September 2023. URL: http://dx.doi.org/10.1371/journal.pone.0290846, doi:10.1371/journal.pone.0290846. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0290846)

[3. (Xiao2023Knockdown) Li Xiao, Ting Zhang, Kaiyue Zheng, Qian Xiao, Weifang Zhang, Dandan Zhang, Dengxun Wu, Chanjuan He, Yifei Zhou, and Ying Liu. Knockdown of secernin 1 inhibit cell invasion and migration by activating the tgf-β/smad3 pathway in oral squamous cell carcinomas. Scientific Reports, September 2023. URL: http://dx.doi.org/10.1038/s41598-023-41504-8, doi:10.1038/s41598-023-41504-8. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-41504-8)

4. (Xiao2020Secernin) Secernin 1 promotes cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas. This article has 0 citations.

[5. (Suehara2011Secernin1) Yoshiyuki Suehara, Naobumi Tochigi, Daisuke Kubota, Kazutaka Kikuta, Robert Nakayama, Kunihiko Seki, Akihiko Yoshida, Hitoshi Ichikawa, Tadashi Hasegawa, Kazuo Kaneko, Hirokazu Chuman, Yasuo Beppu, Akira Kawai, and Tadashi Kondo. Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. Journal of Proteomics, 74(6):829–842, May 2011. URL: http://dx.doi.org/10.1016/j.jprot.2011.02.033, doi:10.1016/j.jprot.2011.02.033. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jprot.2011.02.033)

[6. (Pires2019Secernin1) Geoffrey Pires, Sacha McElligott, Shiron Drusinsky, Glenda Halliday, Marie-Claude Potier, Thomas Wisniewski, and Eleanor Drummond. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in alzheimer’s disease and not in other tauopathies. Acta Neuropathologica Communications, December 2019. URL: http://dx.doi.org/10.1186/s40478-019-0848-6, doi:10.1186/s40478-019-0848-6. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40478-019-0848-6)

[7. (Miyoshi2010SCRN1) Norikatsu Miyoshi, Hideshi Ishii, Koshi Mimori, Mitsugu Sekimoto, Yuichiro Doki, and Masaki Mori. Scrn1 is a novel marker for prognosis in colorectal cancer. Journal of Surgical Oncology, 101(2):156–159, January 2010. URL: http://dx.doi.org/10.1002/jso.21459, doi:10.1002/jso.21459. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jso.21459)

[8. (Drummond2020Phosphorylated) Eleanor Drummond, Geoffrey Pires, Claire MacMurray, Manor Askenazi, Shruti Nayak, Marie Bourdon, Jiri Safar, Beatrix Ueberheide, and Thomas Wisniewski. Phosphorylated tau interactome in the human alzheimer’s disease brain: human neuropathology/tau. Alzheimer’s &amp; Dementia, December 2020. URL: http://dx.doi.org/10.1002/alz.045492, doi:10.1002/alz.045492. This article has 3 citations.](https://doi.org/10.1002/alz.045492)

[9. (Houston2021The) Brendan J. Houston, Liina Nagirnaja, D. Jo Merriner, Anne E. O’Connor, Hidenobu Okuda, Kenan Omurtag, Craig Smith, Kenneth I. Aston, Donald F. Conrad, and Moira K. O’Bryan. The sertoli cell expressed gene secernin‐1 (scrn1) is dispensable for male fertility in the mouse. Developmental Dynamics, 250(7):922–931, January 2021. URL: http://dx.doi.org/10.1002/dvdy.299, doi:10.1002/dvdy.299. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.299)